NCT01317173|Unknown
Factors Related to the Progression of Chronic Kidney Disease
The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease
Loading search results
The Impact of FGF23 and Klotho on Progression of Chronic Kidney Disease
Sponsor study identifier
observational
90
1 country
1
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Chronic kidney disease is a progressive disorder that has been influenced with many factors. Most of the patients has altered Ca P metabolism and these dis orders are the contributing factors of the disease progression. It has been recently documented that FGF23 and Klotho are the key factors of PTH secretion Ca-P metabolism. This study aimed to evaluate the impact of Klotho and FGF23 on the progression of stage 3-4 chronic kidney disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
March 16, 2011
Actual (reported)March 17, 2011
Actual (reported)May 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Progression of kidney disease
Doubling of creatinin, requirement of renal replacement therapy
continuous measurement of kidney functions 3 monthly for two years or until the outcome reached
Evaluation of Ca P metabolism
3 monthly for two years or until the outcome reached
Serum creatinin level rise more than 2 times
Serum creatinin level rise less than 2 times
Patients diagnosed with non-diabetic chronic kidney disease between the ages of 18 and 65 years old.
Ankara Education and Research Hospital
Ankara, Turkey (Türkiye)
First Submitted
March 16, 2011
First Posted
March 17, 2011
Study Start
March 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 2011
Estimated (date passed)Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 17, 2011
Record last verified: 2011-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: